• About
  • Subscribe
  • Advertise
  • Contact
Sunday, March 15, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

UK trials consultation, bilateral cataract surgery on one day, and no eye drops

by Staff Writer
March 17, 2025
in Cataract, Eye disease, International, News, Ophthalmic insights, Ophthalmic organisations, Private ophthalmology clinics, Research, Video
Reading Time: 3 mins read
A A
A company in the UK is trialling a "revolutionary" cataract surgery process. Image: Dusko/stock.adobe.com.

A company in the UK is trialling a "revolutionary" cataract surgery process. Image: Dusko/stock.adobe.com.

Share on FacebookShare on Twitter

Australia is likely to be watching with interest as a British company’s “pioneering” approach to cataract surgery is trialled in the NHS.

For the first time in the UK, and possibly the world, ophthalmic business Optegra Eye Health Care is offering NHS patients a ground-breaking “treble” in cataract care that eliminates the need for post-operative eye drops.

As part of the initiative, patients are offered:

  • Same-day treatment – pre-operative consultation and surgery on the same day.
  • Bilateral surgery – treating both eyes in a single procedure.
  • Revolutionary drop-free surgery.

In a media release, Optegra medical director and consultant ophthalmic surgeon Mr Alastair Stuart, said: “This pilot at our Hampshire hospital is our latest approach in putting patients’ care and experience as well as outcomes at the very centre of what we do.

“For many years now we have been providing high-volume cataract surgeries for the NHS with the lowest complication rates, but we don’t want to stand still.

“We are always looking at ways to innovate and improve our care for patients, and this approach has delivered the ultimate in convenience, as well as a medical advance which really is outstanding,” he said.

Stuart said that, normally after a cataract removal procedure, patients leave with a “rather intense” drop regime.

“They have four different types of drops which they need to take three or four times a day, for up to four weeks.  This is quite a commitment and hassle for patients – in fact it is typically the only thing some patients have difficulty with.

“Due to medical advances, we are now able to apply a steroid injection as part of the surgical procedure, which eliminates the need for any drops whatsoever. This is revolutionary for patients’ post-operative care.

“On top of this, we have provided treatment for both eyes on the same day.”

The normal procedure for NHS patients is to have one eye treated and then return several weeks later for the second eye.

“By treating both eyes on one day – bilateral surgery – the patient leaves with excellent vision in both eyes, which immediately decreases risks of falls, etc,” he said.

“By completing the pre-operative diagnostic tests and consultation on the same day of treatment, patients have been delighted to reduce the number of visits to the hospital – especially if they have some distance to travel and are having to rely on friends or family to be available as the patient cannot drive themselves home.”

More reading

Performing cataract surgery … sustainably

Major Aussie study: Surgeons in public sector seeing more complex cataract cases

Study: Patients less anxious in immediate bilateral cataract surgery

Related Posts

The Humphrey Field Analyzer has evolved over more than 40 years. Image: ZEISS.

ZEISS celebrating over 40 years of Humphrey Field Analyzer

by Rob Mitchell
March 13, 2026

ZEISS is celebrating over 40 years of the Humphrey Field Analyzer with promotional discounts on selected HFA 3 models for...

David Beckham's new range includes sunglasses and optical frames across two product lines. Image: Safilo

Safilo launches David Beckham spring/summer range

by Staff Writer
March 13, 2026

Safilo Group has announced the release of the spring/summer 2026 collection from Eyewear by David Beckham. The company says the...

Bausch + Lomb’s new enVista Aspire intermediate-optimised IOL. Image: B+L.

Intermediate-optimised IOL bringing patient success

by Rob Mitchell
March 13, 2026

An ophthalmologist in New Zealand was the first in the Southern Hemisphere to try Bausch + Lomb’s new enVista Aspire...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited